Lincoln Pharmaceuticals Limited (BOM:531633)
India · Delayed Price · Currency is INR 672.25
-9.85 (-1.44%)
At close: May 6, 2026
Lincoln Pharmaceuticals Market Cap
Lincoln Pharmaceuticals has a market cap or net worth of 13.46 billion as of May 6, 2026. Its market cap has increased by 19.20% in one year.
Market Cap
13.46B
Enterprise Value
11.15B
Revenue
6.52B
Ranking
n/a
PE Ratio
15.33
Stock Price
672.25
Market Cap Chart
Since October 21, 2004, Lincoln Pharmaceuticals's market cap has increased from 138.90M to 13.46B, an increase of 9,593.68%. That is a compound annual growth rate of 23.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 13.46B | 39.12% |
| Dec 31, 2025 | 9.68B | -38.62% |
| Dec 31, 2024 | 15.77B | 29.24% |
| Dec 29, 2023 | 12.20B | 71.47% |
| Dec 30, 2022 | 7.12B | -0.74% |
| Dec 31, 2021 | 7.17B | 47.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kwality Pharmaceuticals | 17.19B |
| Amrutanjan Health Care | 16.68B |
| Fredun Pharmaceuticals | 13.37B |
| Shukra Pharmaceuticals | 13.36B |
| Venus Remedies | 13.08B |
| Syncom Formulations (India) | 12.96B |
| TTK Healthcare | 12.82B |
| Wanbury | 8.83B |